Home Home Home Inbox Home Search

View Abstract

Feasibility of Using a Novel Smartphone Application to Improve Compliance and Engagement in Chronic Obstructive Pulmonary Disease (COPD)

Description

.abstract img { width:300px !important; height:auto; display:block; text-align:center; margin-top:10px } .abstract { overflow-x:scroll } .abstract table { width:100%; display:block; border:hidden; border-collapse: collapse; margin-top:10px } .abstract td, th { border-top: 1px solid #ddd; padding: 4px 8px; } .abstract tbody tr:nth-child(even) td { background-color: #efefef; } .abstract a { overflow-wrap: break-word; word-wrap: break-word; }
A4548 - Feasibility of Using a Novel Smartphone Application to Improve Compliance and Engagement in Chronic Obstructive Pulmonary Disease (COPD)
Author Block: J. T. Krall, R. Alva; Cone Health, Greensboro, NC, United States.
RATIONALE: As of 2015, 58% of adults in the United States aged 50 to 64 and 30% aged 65 and older have a smartphone. Smartphone applications have increasing functionalities including collection and presentation of longitudinal data, decision-making algorithms, and encouragement of self-care. Studies on self-management interventions show health-related quality of life improvement and hospital admission reduction. There are usability concerns, however, in telemonitoring. The primary objective of this study was to evaluate the feasibility of using a novel smartphone application to improve patient engagement and compliance in chronic obstructive pulmonary disease (COPD). The primary outcome was compliance with application functions. Secondary outcomes included person-hours spent by the care team in managing the portal and resulting patient interaction.
METHODS: This feasibility study was conducted over 12 weeks from June to August 2017. Participants were identified from the electronic medical record of a busy private practice with an active diagnosis of COPD and an office visit within the past year. Patients were provided with the smartphone application and Bluetooth-enabled scale and step tracker. The interactive application has reminders for scheduled medications and weight and step tracking. Patients were asked to record in the application medications taken (both scheduled and as needed), daily symptom assessment and weekly COPD assessment test (CAT) score. Patient information was monitored via a portal by a care team composed of two trained medical assistants. Participants and the care team could interact through the application and view real-time progress towards goals.
RESULTS: Of 20 participants enrolled, 17 (85%) completed the 12-week study. The average participant age was 63 years. Forced expiratory volume in one second (FEV1) was classified as very severe in three, severe in four and moderate in ten participants. Average weekly compliance for daily symptom assessment ranged from 68 to 84% and for weekly CAT score ranged from 53 to 100%. The participants recorded scheduled medications 77 to 97% each week. Compliance with recording medication and symptoms was maintained over the study duration. Average time spent daily managing the portal by the care team for all the patients was less than one person-hour.
CONCLUSION: COPD patients at a busy pulmonary office practice had high rate of compliance with a multifunctional smartphone application, which provides patients and providers with real-time feedback about progress towards goals of care. This can promote self-care and improve engagement of patients with healthcare providers with minimal resource allocation by the practice.
Home Home Home Inbox Home Search